Massimo Tilli
Academy for Urban School Leadership
15 Papers
141 Citations
Massimo Tilli is an academic researcher from Academy for Urban School Leadership. The author has contributed to research in topics: Irinotecan & Colorectal cancer. The author has an hindex of 7, co-authored 14 publications.
Chat about Author
Papers
•Journal Article
Intra-arterial Infusion of Irinotecan-loaded Drug-eluting Beads (DEBIRI) versus Intravenous Therapy (FOLFIRI) for Hepatic Metastases from Colorectal Cancer: Final Results of a Phase III Study
Giammaria Fiorentini,Camillo Aliberti,Massimo Tilli,Luca Mulazzani,Francesco Graziano,Paolo Giordani,Andrea Mambrini,Francesco Montagnani,Paolo Alessandroni,Vincenzo Catalano,Paolo Coschiera +10 more
TL;DR: A clinically significant improvement in time to extrahepatic progression was observed for DEBIRI, a reversal of the expectation for a regional treatment, and suggests a benefit ofDEBIRI treatment over standard chemotherapy.
320
•Journal Article
Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.
TL;DR: Irinotecan drug-eluting beads administered as TACE were shown to be active and safe in patients with liver metastases from CRC.
126
•Journal Article
Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Camillo Aliberti,Giammaria Fiorentini,Pier Carlo Muzzio,Fabio Pomerri,Massimo Tilli,Sergio Dallara,Giorgio Benea +6 more
TL;DR: It is suggested that TACE adopting DC Bead®, drug-eluting bead loaded with irinotecan could be proposed as palliative therapy for unresectable and chemotherapy resistant liver metastases from CRC.
95
•Journal Article
Intra-arterial Hepatic Chemoembolization (TACE) of Liver Metastases from Ocular Melanoma with Slow-release Irinotecan-eluting Beads. Early Results of a Phase II Clinical Study
Giammaria Fiorentini,Camillo Aliberti,Alessandro Del Conte,Massimo Tilli,S. Rossi,Pierluigi Ballardini,Gina Turrisi,Giorgio Benea +7 more
TL;DR: TACE containing beads preloaded with IRI is effective in the treatment of LM from UM, and this approach seems to have better efficacy than previous TACE regimens adopted.
74
Locoregional therapy and systemic cetuximab to treat colorectal liver metastases.
Giammaria Fiorentini,Camillo Aliberti,Donatella Sarti,Paolo Coschiera,Massimo Tilli,Luca Mulazzani,Paolo Giordani,Francesco Graziano,Alfonso Marqués Gonzalez,Raul García Marcos,Fernando Gómez Mugnoz,Maurizio Cantore,Stefano Ricci,Vincenzo Catalano,Andrea Mambrini +14 more
TL;DR: DEBIRITUX seems to be efficacious after first line chemotherapy for the treatment of unresectable CRC-LM, and the retrospective evaluation of KRas status showed that the group of patients with wild type KRas had ORR significantly higher than mutant KRas.
21